The healthcare landscape is experiencing a development with the emergence of GLP-1 transdermal systems . These cutting-edge formulations offer a promising approach to delivering glucagon-like peptide-1 drugs for individuals living with type 2 diabetes . Instead of daily shots , a easy-to-use patch applied to the skin could provide a steady dose of